GlassScriptPhysician profile
Matthew Jared Shepard
NPI 1790129146
$40,736.65
in general payments reported to CMS, 2019-2025
14 companies · $23K in 2025
The $23K reported for 2025 was more than what 91% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $219 · 2023: $558 · 2024: $17K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Travel and Lodging: $9,362 · Food and Beverage: $3,985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,000.00 |
| Travel and Lodging | $9,362.41 |
| Food and Beverage | $3,985.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $38,807.69 | 2023-2025 | Gammatile, Gammatile |
| Medtronic, INC. | $573.53 | 2022-2025 | Cd Horizon Spinal System, Unid_pass, Synchromedii |
| Stryker Corporation | $368.03 | 2021-2025 | Everest Spinal System, Surpass Evolve, Adherus Autospray Dural Sealant |
| Monteris Medical Corporation | $198.36 | 2023 | Neuroblate |
| Globus Medical, INC. | $164.50 | 2024 | Excelsius Deformity |
| Abbott Laboratories | $159.71 | 2023 | Proclaim |
| Smith+Nephew, INC. | $136.73 | 2024 | Pico |
| Depuy Synthes Sales INC. | $114.35 | 2021-2022 | |
| Aesculap, INC. | $103.92 | 2022-2025 | Aesculap Ff399r Adaptor |
| Ethicon US, LLC | $27.16 | 2021 | |
| Si-Bone, INC. | $21.66 | 2021 | |
| Surgalign Spine Technologies, INC. | $21.65 | 2022 | |
| Integra Lifesciences Corporation | $20.02 | 2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Boston Scientific Corporation | $19.34 | 2025 | General - Pain Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Shepard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.